Shivom Ventures Limited releases v2.0 which provides researchers with various new features including a library of multi-omics COVID-19 pipelines.
London, United Kingdom – April 16, 2019 – Shivom, a biotechnology data discovery and analysis company optimising the way DNA is shared, secured and analysed through blockchain and AI technology, has released v2.0. Users can now gain access to bulk data onboarding, 7 new pipelines, PayPal integration and more.
Within this release, the product team has added a library of multi-omics Covid-19 pipelines which run off of Shivom’s very own cloud solution. The rapid emergence of COVID-19 across the world has led to massive mortality and morbidity. The genome sequencing of the coronavirus (SARS-CoV-2) can provide clues regarding how the virus has evolved and variants within the genome. “As part of the current pandemic crisis, Shivom has played its part in combating the deadly disease by delivering a curated library of multi-omics analytical pipelines to COVID-19 researchers across the globe. These pipelines allow the researcher to interrogate both viral genome and human genome separately from raw sequencing data, but also combine output for more potent analysis” Said Ibrahim Farah, VP of Product.
The company has curated a set of pipelines, scientists will be able to quickly characterise the novel coronavirus by:
Identifying whether SARS-CoV-2 present in the sample;
Distinguish variant-level differences between samples;
Quantify amount of SARS-CoV present in each sample;
Detect whether susceptibility, symptomatic/asymptomatic status and disease progression is due to human genome variation
Answers to these points are crucial to aid our understanding of disease biology of SARS-CoV-2 which will lead to development of better predictive, preventative and therapeutic measures. Shivom’s intuitive interface allows for users with no experience of programming/bioinformatics analysis to upload fastq files and toggle the desired parameter options, before running the pipelines – all on the same page.
Ease of running pipelines through simple and intuitive user interface.
Safe storage of suspected COVID-19 patients genomic information, for later reanalysis.
Built-in quality control and data manipulation for desired analysis.
Automated summary statistics .pdf reports to share with colleagues.
Traceable and secure via blockchain technology to share COVID-19 genetic data with the rest of the scientific community.
Use existing population-level genomics pipelines, to consolidate understanding of SARS-CoV-2 in relation to other complex genetic disorders.
The release will be made live to the public at 2:00 pm GMT on 16th April.
For more information about Shivom please visit here
To read more about our affiliation with Living DNA please visit here
To read more about our affiliation with Vitl please visit here
To read more about our affiliation with Chronomics please visit here
Shivom provides 1-click access to genomic data and insights. The end-to-end cloud operating system enables computation and analysis to Omics data, accelerating drug discovery and delivering novel insights to personalised medicine. Users are able to gain easy access to genomic data and the ability to run various bioinformatics & AI tools in one environment.
Headquartered in London, UK, Shivom’s mission is to build the world’s largest genetic marketplace. Shivom’s ecosystem of partners and customers spans 10 countries including two active European pilot projects with H2020.
Shivom Social Channels:
Official Homepage: shivom.io
Twitter (English): @projectshivom
Youtube: Shivom’s Channel
Medium: Shivom Official